Psychiatry & Neurology Doctors in Sandy, UT Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Brooke Mastroianni, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 9450 S 1300 E, Sandy, UT 84094 Phone: 801-501-2131

John Patrick Barbuto, MD Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 8074 S 1300 E, Sandy, UT 84094 Phone: 801-565-6500    Fax: 801-561-7323

Dr. Lane Farr Smith, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 10150 Centennial Pkwy, Sandy, UT 84070 Phone: 801-256-7631

Lucas Robinson, APRN, FNP-C Psychiatry & Neurology - Addiction Medicine Medicare: Not Enrolled in Medicare Practice Location: 9980 S 300 W Ste 105, Sandy, UT 84070 Phone: 801-438-3185

Seema Sandhu, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 9844 S 1300 E, Ste 125, Sandy, UT 84094 Phone: 801-501-8233

Andrew P Gasecki, MD, PHD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 8706 S 700 E, Suite 200, Sandy, UT 84070 Phone: 801-446-8156    Fax: 801-446-8393

Claire Louise Arnett Gibson, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 9450 S 1300 E, Sandy, UT 84094 Phone: 801-501-2100

News Archive

Enzo Biochem streamlines operations, expects gross margin improvements

Enzo Biochem, Inc., announced today that it has streamlined its operations, which is anticipated to result in a reduction in annualized operating expenses of more than $4 million beginning in the fiscal 2011 first quarter. These initiatives are also expected to result in increased gross margins. The Company believes that the operating cost reductions, which affect all of its operating businesses as well as corporate overhead, will result in Enzo generating positive cash flow from operations in 2011.

Aspirin for coronary heart prevention is less costly, more effective

Using aspirin for coronary heart prevention is less costly and more effective than doing nothing in men older than 45 with more than 10 percent 10-year-risk of the disease, according to a study by researchers at RTI International, University of Michigan, and University of North Carolina at Chapel Hill.

NAM, FDA's CTP name 2015-2016 class of FDA Tobacco Regulatory Science Fellows

The National Academy of Medicine, formerly the Institute of Medicine, along with the Food and Drug Administration's Center for Tobacco Products (CTP) have named the 2015-2016 class of the FDA Tobacco Regulatory Science Fellows. The five individuals were chosen through a highly selective national competition based on their exceptional, diverse professional qualifications to contribute to the work of CTP.

Good social networks improve breast cancer prognosis

A study published today in Cancer, the journal of the American Cancer Society, reports that breast cancer is less likely to recur among women have a good social network than in those who are more socially isolated.

Read more Medical News

› Verified 9 days ago